GG 1978 SICAF SIF

GG 1978 SICAF SIF is a closed-ended investment fund based in Luxembourg City, Luxembourg, that provides venture financing to clinical-stage biotechnology and health-focused startups. Owned by the GG Trust, the firm primarily targets companies developing food-derived microbial solutions for inflammatory diseases, such as rheumatoid arthritis and bone health. The fund recently participated in the $15 million first close of a targeted $25 million Series B financing round for portfolio company Solarea Bio to support medical food launches. In its venture capital transactions, the organization frequently syndicates with notable co-investors including S2G Ventures, Bold Capital Partners, and Viking Global Investors. Additionally, the fund's ownership structure and beneficiary, Giammaria Giuliani, have been referenced in recent proxy statements for Royalty Pharma as of April 2024. The organization's exact founding year and original founders are not publicly disclosed.